Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, June 01, 2015 3:31:23 PM
bullish
## source: finance.yahoo.com
Mon, 01 Jun 2015 15:34:15 GMT ~ TG Therapeutics Announces the Triple Combination of TG-1101, TGR-1202 and Ibrutinib is Safe and Highly Active in Patients With Advanced B-Cell Malignancies
[at noodls] - Data presented this morning by Dr. Nathan Fowler, MD Anderson Cancer Center, at the 51st American Society of Clinical Oncology (ASCO) Annual Meeting, provides proof of concept that the chemotherapy-free ...
read full: http://www.noodls.com/view/829C44A2BECBB2F03C923944F0CC97B650D12673
*********************************************************
Mon, 01 Jun 2015 15:00:00 GMT ~ TG Therapeutics Announces the Triple Combination of TG-1101, TGR-1202 and Ibrutinib is Safe and Highly Active in Patients With Advanced B-Cell Malignancies
[GlobeNewswire] - Data presented this morning by Dr. Nathan Fowler, MD Anderson Cancer Center, at the 51st American Society of Clinical Oncology (ASCO) Annual Meeting, provides proof of concept that the chemotherapy-free ...
read full: http://finance.yahoo.com/news/tg-therapeutics-announces-triple-combination-150000040.html
*********************************************************
Mon, 01 Jun 2015 06:54:00 GMT ~ 2:54 am TG Therapeutics presents TG-1101 Plus TGR-1202 data; data from both studies continues to demonstrate a favorable safety profile with a high level of activity
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#tgtx
*********************************************************
Sun, 31 May 2015 16:34:07 GMT ~ TG Therapeutics, Inc. Announces Presentations of Its Proprietary Combination of TG-1101 Plus TGR-1202 as Well as TGR-1202 as a Single Agent in Ongoing Phase I/Ib Dose Escalation Clinical Studies
[at noodls] - Triple therapy cohort of the combination study to be presented separately as an oral presentation tomorrow morning, Monday, June 1st, 2015, at 51st American Society of Clinical Oncology (ASCO) Annual Meeting ...
read full: http://www.noodls.com/view/3123E36B06820B2846F5547B9F7D38D3B545C7EE
*********************************************************
Sun, 31 May 2015 16:00:00 GMT ~ TG Therapeutics, Inc. Announces Presentations of Its Proprietary Combination of TG-1101 Plus TGR-1202 as Well as TGR-1202 as a Single Agent in Ongoing Phase I/Ib Dose Escalation Clinical Studies
[GlobeNewswire] - Triple therapy cohort of the combination study to be presented separately as an oral presentation tomorrow morning, Monday, June 1st, 2015, at 51st American Society of Clinical Oncology (ASCO) Annual Meeting...
read full: http://finance.yahoo.com/news/tg-therapeutics-inc-announces-presentations-160000452.html
*********************************************************
$TGTX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TGTX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TGTX/company-info
Ticker: $TGTX
OTC Market Place: Not Available
CIK code: 0001001316
Company name: TG Therapeutics, Inc.
Company website: http://www.manhattanpharma.com
Incorporated In: DE, USA
Business Description:
$TGTX share structure
## source: otcmarkets.com
Market Value: $796,981,647 a/o May 29, 2015
Shares Outstanding: 50,634,158 a/o May 08, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$TGTX extra dd links
Company name: TG Therapeutics, Inc.
Company website: http://www.manhattanpharma.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TGTX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TGTX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TGTX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/news - http://finance.yahoo.com/q/h?s=TGTX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TGTX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TGTX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TGTX
DTCC (dtcc.com): http://search2.dtcc.com/?q=TG+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=TG+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=TG+Therapeutics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.manhattanpharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.manhattanpharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.manhattanpharma.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TGTX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001001316&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TGTX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TGTX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TGTX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TGTX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TGTX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TGTX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TGTX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TGTX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TGTX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TGTX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TGTX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TGTX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TGTX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TGTX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TGTX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TGTX
$TGTX DD Notes ~ http://www.ddnotesmaker.com/TGTX
Recent TGTX News
- New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis • GlobeNewswire Inc. • 09/18/2024 11:15:00 AM
- New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment • GlobeNewswire Inc. • 09/18/2024 11:00:00 AM
- Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 • PR Newswire (US) • 09/06/2024 10:43:00 PM
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:03:55 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/09/2024 08:01:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:08:39 AM
- TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/05/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:48:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 07:08:53 PM
- Form PX14A6G - Notice of exempt solicitation submitted by non-management • Edgar (US Regulatory) • 06/10/2024 03:23:35 PM
- TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/07/2024 11:50:00 AM
- TG Therapeutics to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 06/03/2024 11:30:00 AM
- TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting • GlobeNewswire Inc. • 05/31/2024 11:30:00 AM
- TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting • GlobeNewswire Inc. • 05/28/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:59:11 PM
- TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 04/30/2024 08:55:29 PM
- TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/18/2024 11:30:00 AM
- TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/15/2024 11:30:00 AM
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 03/08/2024 12:30:00 PM
- TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum • GlobeNewswire Inc. • 03/01/2024 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 10:23:27 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM